¿Las dietas de ayuno afectan a las hormonas de una mujer?
LUNES, 31 de octubre de 2022 (HealthDay News) — El ayuno intermitente se ha popularizado como una forma de perder peso sin tener que limitar los tipos de alimentos que una persona come.Pero hay poca investigación sobre cómo comer solo durante algunas…
Learn MoreLos corazones de donantes que tuvieron COVID son seguros para el trasplante
LUNES, 31 de octubre de 2022 (HealthDay News) — Una persona con insuficiencia cardiaca que tiene una necesidad urgente de un nuevo corazón podría haberse enfrentado a retrasos para obtenerlo durante la pandemia, cuando los donantes potenciales tenían…
Learn MoreLos matrimonios malos ponen en peligro la recuperación tras un ataque cardiaco
LUNES, 31 de octubre de 2022 (HealthDay News) — Un matrimonio malo puede romperle el corazón… literalmente.Los sobrevivientes a un ataque cardiaco que tienen una relación estresante son más propensos a experimentar una recuperación difícil, informa…
Learn MoreEven a Little Coffee in Pregnancy Might Stunt a Child’s Growth
TUESDAY, Nov. 1, 2022 (HealthDay News) — Most pregnant women are told it’s safe to have one cup of coffee a day because it won’t trigger miscarriages or preterm deliveries, but new research suggests a surprising risk: Moms-to-be who consume caffeine,…
Learn MoreTravel Times to Abortion Facilities Have Lengthened After Dobbs Decision: Study
TUESDAY, Nov. 1, 2022 (HealthDay News) — A new analysis illustrates the impact of the U.S. Supreme Court’s decision to overturn Roe v. Wade: In numerous states, women now have no choice but to travel long distances to get an abortion.One-third of Ame…
Learn MoreNew Malaria Antibody Drug Prevents Infection in Adults for 6 Months
TUESDAY, Nov. 1, 2022 (HealthDay News) — A new malaria antibody treatment may keep more people free of the sometimes deadly disease for up to six months in regions where infection rates are high. Instead of requiring the immune system to make enough …
Learn MoreCombo Drug May Fight Tough-to-Treat UTIs
TUESDAY, Nov. 1, 2022 (HealthDay News) — Doctors could soon have access to a new weapon in the ongoing battle against antibiotic-resistant bacteria.An experimental combination antibiotic appears to offer a new option for doctors treating stubborn dru…
Learn MoreUSPSTF: Hormone Therapy Not Advised for Primary Prevention of Chronic Conditions
TUESDAY, Nov. 1, 2022 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends against use of combined estrogen and progestin, or use of estrogen alone in those who have had a hysterectomy, for primary prevention of chronic cond…
Learn MoreGI Bleeding Lower With Apixaban Versus Other DOACs in A-Fib
TUESDAY, Nov. 1, 2022 (HealthDay News) — For patients with atrial fibrillation (AF), apixaban use is associated with a lower risk for gastrointestinal bleeding (GIB) compared with other direct oral anticoagulants (DOACs), according to a study publish…
Learn MoreBenefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
TUESDAY, Nov. 1, 2022 (HealthDay News) — Among CYP2C19 loss-of-function allele carriers with minor stroke or transient ischemic attack, those with normal renal function rather than impaired renal function derive greater benefit from ticagrelor-aspiri…
Learn More